Dolby Laboratories, Inc. (DLB) Insider Kevin J. Yeaman Sells 68,548 Shares

Dolby Laboratories, Inc. (NYSE:DLB) insider Kevin J. Yeaman sold 68,548 shares of the business’s stock in a transaction that occurred on Monday, February 12th. The shares were sold at an average price of $59.66, for a total transaction of $4,089,573.68. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website.

Kevin J. Yeaman also recently made the following trade(s):

  • On Thursday, February 8th, Kevin J. Yeaman sold 50,000 shares of Dolby Laboratories stock. The shares were sold at an average price of $61.32, for a total transaction of $3,066,000.00.
  • On Thursday, February 8th, Kevin J. Yeaman sold 100,000 shares of Dolby Laboratories stock. The shares were sold at an average price of $62.33, for a total transaction of $6,233,000.00.
  • On Monday, December 18th, Kevin J. Yeaman sold 11,130 shares of Dolby Laboratories stock. The shares were sold at an average price of $62.47, for a total transaction of $695,291.10.
  • On Tuesday, December 19th, Kevin J. Yeaman sold 17,590 shares of Dolby Laboratories stock. The shares were sold at an average price of $62.45, for a total transaction of $1,098,495.50.

Dolby Laboratories, Inc. (DLB) traded up $0.08 on Tuesday, reaching $62.52. 340,307 shares of the company’s stock traded hands, compared to its average volume of 451,850. Dolby Laboratories, Inc. has a 12 month low of $48.00 and a 12 month high of $74.29. The stock has a market capitalization of $6,231.11, a P/E ratio of 99.24, a P/E/G ratio of 5.07 and a beta of 0.78.

Dolby Laboratories (NYSE:DLB) last released its quarterly earnings data on Wednesday, January 24th. The electronics maker reported $0.79 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.44 by $0.35. Dolby Laboratories had a net margin of 6.06% and a return on equity of 12.02%. The company had revenue of $287.80 million during the quarter, compared to the consensus estimate of $265.75 million. During the same period in the previous year, the firm earned $0.66 earnings per share. Dolby Laboratories’s revenue for the quarter was up 8.1% on a year-over-year basis. sell-side analysts anticipate that Dolby Laboratories, Inc. will post 0.99 EPS for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, February 14th. Shareholders of record on Monday, February 5th will be paid a dividend of $0.16 per share. The ex-dividend date of this dividend is Friday, February 2nd. This represents a $0.64 annualized dividend and a yield of 1.02%. Dolby Laboratories’s dividend payout ratio is currently 101.59%.

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Eagle Boston Investment Management Inc. purchased a new stake in Dolby Laboratories during the fourth quarter worth approximately $202,000. State of Alaska Department of Revenue acquired a new position in shares of Dolby Laboratories during the fourth quarter worth $198,000. Icon Wealth Partners LLC acquired a new position in shares of Dolby Laboratories during the fourth quarter worth $215,000. Zurcher Kantonalbank Zurich Cantonalbank lifted its position in shares of Dolby Laboratories by 48.9% during the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 3,472 shares of the electronics maker’s stock worth $215,000 after purchasing an additional 1,141 shares in the last quarter. Finally, Berkshire Asset Management LLC PA acquired a new position in shares of Dolby Laboratories during the third quarter worth $200,000. Institutional investors own 52.74% of the company’s stock.

DLB has been the subject of a number of recent analyst reports. B. Riley restated a “buy” rating and issued a $65.50 target price on shares of Dolby Laboratories in a report on Thursday, October 26th. Zacks Investment Research downgraded shares of Dolby Laboratories from a “hold” rating to a “sell” rating in a research note on Thursday, January 18th. Finally, JPMorgan Chase & Co. boosted their price objective on shares of Dolby Laboratories from $63.00 to $70.00 and gave the stock a “neutral” rating in a research note on Thursday, January 25th. Two analysts have rated the stock with a sell rating, three have given a hold rating and one has given a buy rating to the company. The stock currently has a consensus rating of “Hold” and an average target price of $62.00.

WARNING: “Dolby Laboratories, Inc. (DLB) Insider Kevin J. Yeaman Sells 68,548 Shares” was originally posted by American Banking News and is owned by of American Banking News. If you are accessing this piece on another publication, it was stolen and republished in violation of United States & international trademark and copyright laws. The correct version of this piece can be read at https://www.americanbankingnews.com/2018/02/13/dolby-laboratories-inc-dlb-insider-kevin-j-yeaman-sells-68548-shares.html.

Dolby Laboratories Company Profile

Dolby Laboratories, Inc designs and manufactures audio and imaging products for the cinema, television, broadcast and entertainment industries. Its products for cinema include Digital Cinema Servers and Cinema Audio Products, and broadcast and other include Dolby Conference Phone and Other Products. It offers services to support theatrical and television production for cinema exhibition, broadcast and home entertainment, including equipment training and maintenance, mixing room alignment and equalization, as well as audio, color and light image calibration.

Insider Buying and Selling by Quarter for Dolby Laboratories (NYSE:DLB)

Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply